ARCHIVES

DCE Advisers Okay Cooperative Agreements For Epidemiolgic Of Esophageal Cancers

This article is from The Cancer Letter archive.

Vol. 17 No. 13 | March 29, 1991

Download PDF Visit The Full Archive

Related Articles

Cancer, AIDS Patient Advocates List Drug Development Concerns

May 12, 1989

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

NCI Study Tests Method For Biomarker Validation

July 24, 2009

In Brief: Ford To Go Along With Cooper As Health Chief, Fredrickson As NIH Director, W.H. Sources Says

March 14, 1975

NCI spends A Third Of Its Budget On Prevention

May 15, 1992